ADVERTISEMENT
The Alzheimer’s Association International Conference 2016
The Alzheimer’s Association was founded in 1980 by Jerome H Stone and representatives from several family support groups after they met with the National Institute on Aging to explore the value of a national, independent, nonprofit organization that would complement federal efforts surrounding Alzheimer’s disease (AD).
Today, as the largest nonprofit funder of AD research, the Association is committed to accelerating the progress of new treatments, preventions, and, ultimately, a cure. In pursuit of their vision of a world without AD, the Association hosts a conference each year to bring together like-minded health care professionals working to fight AD and dementia.
The Alzheimer’s Association International Conference® 2016 (AAIC®) is the world’s largest forum for the dementia research community. Researchers, clinicians, care providers, and students from over 70 countries gather at AAIC to network and discuss the latest dementia study results.
AAIC 2016 (#AAIC16) was held from July 22-28 in Toronto, Canada, and featured more than 90 sessions, 1700 posters, and 475 presentations.
Thinning Retinal Nerve Associated With Poor Cognitive Function
One presentation at AAIC 2016 suggested there is a significant association between thinner macular retinal nerve fiber layer (RNFL) and poor cognition.
Odor Identification Impairment May Signal Transition to Dementia
Odor identification impairment may be a predictor of the transition to dementia, according to a presentation at AAIC 2016 by Seonjoo Lee, PhD, Columbia University Medical Center (New York, NY).
Misdiagnosing Alzheimer's: Clinical Diagnosis vs Neuropathological Confirmation
One study presented at the Conference suggests the need for more sensitive Alzheimer’s disease assessment tools in order to mitigate diagnostic errors.
Read More
Treating Alzheimer’s in Older Adults Lowers All-Cause Health Care Costs, Study Suggests
Findings from a study presented at AAIC 2016 suggest that dementia treatment can result in lower all-cause health care costs and lower mortality rates compared with untreated patients.
Read More
